MDxHealth (MDXH) Income towards Parent Company (2021 - 2026)

MDxHealth has disclosed Income towards Parent Company across 6 years of filings, most recently posting -$8.9 million for Q1 2026.

• Income towards Parent Company for Q1 2026 came in at -$8.9 million, up 3.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$29.0 million (up 24.92% YoY), and the FY2025 annual result was -$33.5 million, up 11.95% from the prior year.
• Income towards Parent Company came in at -$8.9 million for Q1 2026 at MDxHealth, up from -$12.1 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of -$71766.0 in Q2 2025 to a low of -$18.1 billion in Q2 2022.
• The 5-year median for Income towards Parent Company is -$10.6 million (2023), against an average of -$1.1 billion.
• Across the five-year window, Income towards Parent Company tumbled 93.66% in 2022 and surged 99.94% in 2023, its largest moves.
• MDxHealth's Income towards Parent Company stood at -$12.2 million in 2022, then grew by 12.02% to -$10.7 million in 2023, then surged by 37.07% to -$6.7 million in 2024, then sank by 78.98% to -$12.1 million in 2025, then rose by 26.55% to -$8.9 million in 2026.
• The last three Income towards Parent Company figures came in at -$8.9 million (Q1 2026), -$12.1 million (Q4 2025), and -$8.0 million (Q3 2025), per Business Quant data.